1. Home
  2. Products
  3. Portfolio
  4. Chondroitin sulfate
chondroitin sulfate bioiberica

Chondroitin sulfate

For the symptomatic treatment of osteoarthritis and of joint discomfort
What is it?
  • Chondroitin sulfate is a glycosaminoglycan that constitutes an important structural component of the extracellular cartilage matrix and is responsible for its resistance to compression.
  • As we age, our cartilage starts to wear down and can lead to the onset of degenerative joint diseases like osteoarthritis. It has been proven that chondroitin sulfate can help slow this process.
Efficacy
  • Chondroitin sulfate-API is considered a Symptomatic Slow Acting Drug for Osteoarthritis.
  • For people suffering from joint disorders, such as osteoarthritis, it offers an effective and welcome treatment for joint pain.
  • Chondroitin sulfate-API is currently recommended by national and international therapeutic guidelines, with clinical trials showing its effectiveness in reducing joint pain and increasing mobility.
  • Chondroitin sulfate-API from Bioiberica is the chemical reference in the European Pharmacopoeia. It is available from bovine or porcine origin and capable for use for pharmaceuticals and injectable products.
  • Bioiberica also offers nutraceutical quality chondroitin sulfate which is predominantly used as a main ingredient in nutraceutical and veterinary formulations.
  • Our Chondroitin sulfate is compliant with the most restrictive and up-to-date monographs (EP, USP, JP, KP, RP) and is GMP certified.
Product information
  • SOURCE: Bovine or porcine cartilage.
  • PURITY: 90-100%
  • USES:
    • Pharmaceuticals
    • Injectable products
    • Nutraceuticals
  • QUALITIES: European, United States, Japanese, Korean and Russian Pharmacopoeias.
  • DMFs/CERTIFICATIONS:
    • DMF for all qualities on demand
    • Europe: CEP (double) TSE
    • Japan:  Accreditation certified by foreign drug manufacturer
    • Korea: KFDA registration
    • GMP certificate
  • INDICATION: For the symptomatic treatment of osteoarthritis.
  • PRESENTATION: Hygroscopic powder - almost white.
  • RECOMMENDED DOSE: 800 mg/day (EU), 1.200 mg/day (US).
  • REGULATORY STATUS: Active Pharmaceutical Ingredient and Dietary Supplement Ingredient.
  • STORAGE AND PACKAGING: Store at room temperature. Packaged in a double bag in a 25 KG drum.
  • RE-ANALYSIS/EXPIRATION PERIOD: Re-analysis period of four years from the manufacture date.

Other products